학술논문

A network-based approach to identify deregulated pathways and drug effects in metabolic syndrome.
Document Type
Article
Source
Nature Communications; 11/18/2019, Vol. 10 Issue 1, p1-14, 14p
Subject
SYSTEMS biology
METABOLIC syndrome
PHARMACOLOGY
TYPE 2 diabetes
HIGH density lipoproteins
HYPERGLYCEMIA
CARDIOVASCULAR diseases
DRUG interactions
Language
ISSN
20411723
Abstract
Copyright of Nature Communications is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)